HUP0300730A2 - Eljárás instabil angina pectoris kezelésére - Google Patents

Eljárás instabil angina pectoris kezelésére

Info

Publication number
HUP0300730A2
HUP0300730A2 HU0300730A HUP0300730A HUP0300730A2 HU P0300730 A2 HUP0300730 A2 HU P0300730A2 HU 0300730 A HU0300730 A HU 0300730A HU P0300730 A HUP0300730 A HU P0300730A HU P0300730 A2 HUP0300730 A2 HU P0300730A2
Authority
HU
Hungary
Prior art keywords
angina pectoris
unstable angina
treating unstable
treating
endothelinal
Prior art date
Application number
HU0300730A
Other languages
English (en)
Inventor
Peter Lerch
Thomas F. Lüscher
Georg Noll
Original Assignee
Zlb Bioplasma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlb Bioplasma Ag filed Critical Zlb Bioplasma Ag
Publication of HUP0300730A2 publication Critical patent/HUP0300730A2/hu
Publication of HUP0300730A3 publication Critical patent/HUP0300730A3/hu
Publication of HU230151B1 publication Critical patent/HU230151B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Supports For Pipes And Cables (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány rekonstituált nagy sűrűségű lipoprotein (rHDL)alkalmazására vonatkozik, mely alkalmazással magas koleszterinszintesetén javítható az endothelinilis funkció és gyógyíthatók vagymegelőzhetők az akut koszorúér-betegségek, mint amilyen az instabilangina pektoris vagy a miokardiális infarktus. Ó
HU0300730A 2000-07-20 2001-07-20 Rekonstituált HDL alkalmazása érrendszeri betegségek javítására használható gyógyszerkészítmények előállításában HU230151B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10035352.5 2000-07-20
DE10035352A DE10035352A1 (de) 2000-07-20 2000-07-20 Verfahren zur Behandlung von instabiler Angina pectoris
PCT/EP2001/008425 WO2002007753A2 (de) 2000-07-20 2001-07-20 Verfahren zur behandlung von instabiler angina pectoris

Publications (3)

Publication Number Publication Date
HUP0300730A2 true HUP0300730A2 (hu) 2003-12-29
HUP0300730A3 HUP0300730A3 (en) 2010-07-28
HU230151B1 HU230151B1 (hu) 2015-09-28

Family

ID=7649620

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300730A HU230151B1 (hu) 2000-07-20 2001-07-20 Rekonstituált HDL alkalmazása érrendszeri betegségek javítására használható gyógyszerkészítmények előállításában

Country Status (17)

Country Link
US (1) US7053049B2 (hu)
EP (1) EP1303294B1 (hu)
JP (1) JP4928047B2 (hu)
KR (2) KR100864079B1 (hu)
AT (1) ATE333887T1 (hu)
AU (2) AU2001282004B2 (hu)
CA (1) CA2418238C (hu)
DE (2) DE10035352A1 (hu)
DK (1) DK1303294T3 (hu)
ES (1) ES2266234T3 (hu)
HU (1) HU230151B1 (hu)
IL (2) IL154006A0 (hu)
NO (1) NO329848B1 (hu)
NZ (1) NZ523784A (hu)
PL (1) PL204406B1 (hu)
WO (1) WO2002007753A2 (hu)
ZA (1) ZA200300509B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000924A1 (ja) * 2005-06-28 2007-01-04 Osaka University プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法
US7956035B2 (en) * 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
CA2780482A1 (en) 2008-11-17 2010-05-10 Anil K. Sood Hdl particles for delivery of nucleic acids
CN104487253B (zh) 2012-09-25 2016-05-25 惠普发展公司，有限责任合伙企业 液滴检测
ITMI20131300A1 (it) * 2013-08-01 2015-02-02 Nobil Bio Ricerche Srl Composizione per il riempimento di difetti ossei e parodontali
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
GB2603950A (en) 2021-02-22 2022-08-24 Reckitt & Colman Overseas Hygiene Home Ltd Effervescent germicidal compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
JPH10218861A (ja) * 1997-02-04 1998-08-18 Yamanouchi Pharmaceut Co Ltd 新規なフェネタノール誘導体又はその塩
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
GB9919713D0 (en) 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
AUPQ429399A0 (en) * 1999-11-26 1999-12-23 Heart Research Institute, The Oxidized apolipoproteins and methods of use
AU777788B2 (en) * 1999-11-26 2004-10-28 Heart Research Institute Limited, The Oxidized apolipoproteins and methods of use

Also Published As

Publication number Publication date
NO329848B1 (no) 2011-01-10
AU8200401A (en) 2002-02-05
HUP0300730A3 (en) 2010-07-28
NO20030137D0 (no) 2003-01-10
WO2002007753A3 (de) 2003-02-13
KR20030026980A (ko) 2003-04-03
CA2418238C (en) 2012-06-05
PL204406B1 (pl) 2010-01-29
IL154006A (en) 2010-05-31
KR20070108955A (ko) 2007-11-13
DE50110552D1 (de) 2006-09-07
HU230151B1 (hu) 2015-09-28
EP1303294B1 (de) 2006-07-26
ES2266234T3 (es) 2007-03-01
EP1303294A2 (de) 2003-04-23
KR100864079B1 (ko) 2008-10-16
US20040014654A1 (en) 2004-01-22
WO2002007753A2 (de) 2002-01-31
CA2418238A1 (en) 2003-01-16
NO20030137L (no) 2003-01-10
DE10035352A1 (de) 2002-01-31
DK1303294T3 (da) 2006-10-30
US7053049B2 (en) 2006-05-30
ZA200300509B (en) 2004-02-17
JP2004504355A (ja) 2004-02-12
NZ523784A (en) 2004-06-25
AU2001282004B2 (en) 2006-02-02
ATE333887T1 (de) 2006-08-15
PL366395A1 (en) 2005-01-24
JP4928047B2 (ja) 2012-05-09
IL154006A0 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
CY1106180T1 (el) Σκευασματα διασπορας τα οποια πepιεχουν αναστολεις λιπασης
TR200200068T2 (tr) Nematisital triflüorobütenler
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
ATE209191T1 (de) Parazinon thrombin inhibitoren
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
ATE486915T1 (de) Azeotrop-ähnliche zusammensetzung von 1,2-dichlor-3,3,3-trifluorpropen und fluorwasserstoff
WO2003047558A3 (en) Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors
HUP0300730A2 (hu) Eljárás instabil angina pectoris kezelésére
BR9913533A (pt) Processos para tratar hipertensão e composições para uso nos mesmos
SE9604348D0 (sv) Användning av hydroxyguanidiner
DE69429816T2 (de) C1-Esterasehemmer zur Verringerung von Myokardschäden bei akutem Herzinfarkt
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE305311T1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
DE60219940D1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DK0996439T3 (da) Beta-alkoxyacrylater mod malaria
ATE440108T1 (de) Plasmin-inhibitoren von der australischen braunen schlange, pseudonaja textilis textilis
ATE286933T1 (de) Zugabe von behandlungsmitteln bei festphasenpolymerisationsverfahren
WO2005002505A3 (en) Apolipoprotein c-1 induced apoptosis
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
DK1144348T3 (da) LTA4-hydrolaseinhibitorer
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: CSL BEHRING AG, CH

Free format text: FORMER OWNER(S): ZLB BIOPLASMA AG, CH; ZLB BEHRING AG, CH

MM4A Lapse of definitive patent protection due to non-payment of fees